Topics

Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

02:30 EST 14 Jan 2019 | Sciad Newswire

Original Article: Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development

NEXT ARTICLE

More From BioPortfolio on "Solentim and ATUM announce technology collaboration to enable rapid, high expression, stable cell line development"

Quick Search

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...